Mahmoud Elshawwaf

Experienced Physician skilled in examining patient histories, assessing conditions and conducting physical examinations. Professionally develops individualized treatments to deal with symptoms and root causes. Works thoroughly, precisely and with balanced approach incorporating patient needs and optimal treatments.

Mississippi, state medical license

• Department of Surgery, Liver Transplant, Houston Methodist Research Institute, Rafik Mark Ghobrial, MD, "Association of Adaptive Immune Activation and Regulation With Outcomes Following Orthotopic Liver Transplantation".
• Department of Internal Medicine, University of Texas MD Anderson Cancer Center-Houston Methodist Research Institute, Rafik Mark Ghobrial, MD, "Genome-Wide Association Study (GWAS) in Hepatocellular Carcinoma (HCC)".
• Transplant Hepatology, Houston Methodist Hospital, David W. Victor, MD, "Evaluating the safety and efficacy of selonsertib, for patients with bridging fibrosis (F3) due to nonalcoholic steatohepatitis (NASH)".
• Department of Surgery, Liver Transplant, Houston Methodist Hospital, Rafik Mark Ghobrial, MD, Ashish Saharia, MD, "International Liver Protect Trial to Evaluate The Effectiveness of The Portable Organ Care System (OCS) For Preserving Donor Livers For Transplantation".
• Transplant Pulmonology, Houston Methodist Academic Medicine Associates-Internal Medicine, J. Georges Youssef, MD, "RLF-100 for the Prevention and Treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome in COVID-19. Multi-Center".

• Abdelrahim M, Victor D, Esmail A, Kodali S, Graviss EA, Nguyen DT, Moore LW, Saharia A, McMillan R, Fong JN, Uosef A, Elshawwaf M, et al. "Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience". Cancers. 2022; 14(3):650. https://doi.org/10.3390/cancers14030650
• Ahmed Uosef, Nicole Vaughn, Xiufeng Chu, Mahmoud Elshawwaf, Ahmed Adel Abbas Abdelshafy, Kamal Mamdoh Kamal Elsaid, Rafik Mark Ghobrial, Malgorzata Kloc. "Siponimod (Mayzent) downregulates RhoA and cell surface expression of the S1P1 and CX3CR1 receptors in mouse RAW 264.7 macrophages"
• Mark J Hobeika, Ashish Saharia, Constance M Mobley, Terri Menser, Duc T Nguyen, Edward A Graviss, Robert R McMillan, Hemangshu Podder, Joy V Nolte Fong, Stephen L Jones, Stephanie G Yi, Mahmoud Elshawwaf, Ahmed O Gaber, Rafik M Ghobrial. "Donation after circulatory death liver transplantation: An in-depth analysis and propensity score–matched comparison". Clin Transplant. 2021; 35:e14304. https://doi.org/10.1111/ctr.14304
• Jihad Georges Youssef, Mohammad Z Bitar, Faisal Zahiruddin, Mukhtar Al-Saadi, Mahmoud Elshawwaf, Simon Yau, Ahmad Goodarzi, Jonathan C Javitt. "Brief Report: Rapid Clinical Recovery From Critical Coronavirus Disease 2019 With Respiratory Failure in a Pregnant Patient Treated With IV Vasoactive Intestinal Peptide". Crit Care Explor. 2022 Jan 5;4(1):e0607. doi: 10.1097/CCE.0000000000000607. PMID: 35018346; PMCID: PMC8735760.
• Abdullah Esmail, David Victor, Sudha Kodali, Edward A Graviss, Duc T Nguyen, Linda W Moore, Ashish Saharia, Robert McMillan, Joy N Fong, Ahmed Uosef, Mahmoud Elshawwaf, Kirk Heyne, Rafik Mark Ghobrial, Maen Abdelrahim. "Combination of transarterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) compared to TACE alone as bridging therapy transplant recipients with hepatocellular carcinoma: An update".. JCO 40, e16201-e16201(2022). DOI:10.1200/JCO.2022.40.16_suppl.e16201
• Malgorzata Kloc, Ahmed Uosef, Mahmoud Elshawwaf, Ahmed Adel Abbas Abdelshafy, Kamal Mamdoh Kamal Elsaid, Jacek Z Kubiak, Rafik Mark Ghobrial. "The Macrophages and Intestinal
  Symbiosis. Results and Problems in Cell Differentiation, 2020, 69, pp. 605–616.
• M Abdelrahim, J Fong, A Esmail, D Victor, EA Graviss, DT Nguyen, LW Moore, A Saharia, R McMillan, S Kodali, A Uosef, M Elshawwaf, K Heyne, RM Ghobrial. "Transarterial chemoembolization (TACE) plus Sorafenib compared to TACE alone in transplant recipients with hepatocellular carcinoma." TRANSPLANTATION. Vol. 106. No. 8 S. TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA: LIPPINCOTT WILLIAMS & WILKINS, 2022.
• Ashish Saharia, Lucy Potter, Flavio Baio, Mahmoud Elshawwaf, Maen Abdelrahim, Kirk Heyne. "Commentary on Neoadjuvant Versus Surgery First Approach in Resectable Pancreatic Ductal Adenocarcinoma". American Journal of Clinical Oncology 43(10):p 753-754, October 2020. | DOI: 10.1097/COC.0000000000000743

• Elshawwaf, M., Green, J., Bell, T., Harris, S., (2023). "ANCA vasculitis in the setting of Hydralazine use" "Baptist Memorial Annual Scholarly Activity Symposium" Oxford, Ms.
• Elshawwaf M, Muthu S, Gupta S, Fahhoum R, (April 2023) "The Cancer that Reared its Ugly Head: Leptomeningeal Metastasis as a Primary Presentation of Colon Cancer". Presented at Baptist Memorial Hospital Poster Symposium. Memphis, TN.
• Green J, Ghaly M, Elshawwaf M, Edwards M, "GAD65 Autoimmun Encephalitis in a 23 year old Male: A case report". Baptist Memorial Annual Activity Symposium.
• Uosef, A., & Vaughn, N., Elshawwaf, M., Ghobrial, R.M., Kloc, M. (August 2019). “The effect of Siponimod on RhoA and mTOR pathway in mouse macrophages.” Poster presented at: 2nd Annual MAPTA (Methodist Association for Postdoctoral and Trainee Affairs) Summer Science Symposium; Houston, TX, USA.
• · J. V. Nolte Fong, M. Elshawwaf, L. W. Moore, E. A. Graviss, D. T. Nguyen, R. Angell, A. Uosef, T. Hirase, C.M. Mobley, R. Ghobrial “Nutritional Inadequacy is an Independent Predictor of Sepsis Post-liver
  Transplantation” 2021 American Transplant Congress [abstract]. Am J Transplant. 2021; 21 (suppl 3).
• · Abdullah Esmail, David Victor, Sudha Kodali, Edward A. Graviss, Duc T. Nguyen, Linda W. Moore, Ashish
  Saharia, Robert McMillan, Joy N. Fong, Ahmed Uosef, Mahmoud Elshawwaf, Kirk Heyne, Rafik Mark Ghobrial,
  Maen Abdelrahim “Combination of Transarterial Chemoembolization (TACE) and Tyrosine kinase
  inhibitors (TKIs) Compared to TACE alone as Bridging therapy Transplant Recipients with Hepatocellular Carcinoma: An Update.” American society of clinical oncology, Abstract#370214